Megace and Cephalexin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Megace (megestrol acetate) and Cephalexin (cephalexin). Common drug interactions include gingival swelling among females and pain among males.
The phase IV clinical study analyzes what interactions people have when they take Megace and Cephalexin. It is created by eHealthMe based on reports of 118 people who take the same drugs from the FDA, and is updated regularly.
What is Megace?
Megace has active ingredients of megestrol acetate. It is often used in weight loss. eHealthMe is studying from 10,095 Megace users. Check the latest studies of Megace.
What is Cephalexin?
Cephalexin has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 30,580 Cephalexin users. Check the latest studies of Cephalexin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
118 people who take Megace and Cephalexin together, and have interactions are studied.
What are the common drug interactions of Megace and Cephalexin, by gender? *
What are the common drug interactions of Megace and Cephalexin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Megace and Cephalexin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Megace (10,095 reports)
- Cephalexin (30,580 reports)
Browse all drug interactions of Megace and Cephalexin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Megace:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cephalexin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Megace and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cephalexin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .
- Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on megestrol acetate and cephalexin (the active ingredients of Megace and Cephalexin, respectively), and Megace and Cephalexin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Magnesium Gluconate and Rashes for Women aged 30-39 - a second ago
- Magnesium Gluconate and Rash Generalised for Women aged 30-39 - a second ago
- Magnesium Gluconate and Skin Redness Or Inflammation for Women aged 30-39 - 2 seconds ago
- Magnesium Gluconate and Skin Rash for Women aged 30-39 - 2 seconds ago
- Magnesium Gluconate and Skin Lesion for Women aged 30-39 - 2 seconds ago
- Drug interactions of Olanzapine and Rosuvastatin Calcium - 2 seconds ago
- Magnesium Gluconate and Rubor for Women aged 30-39 - 3 seconds ago
- Magnesium Gluconate and Erythema for Women aged 30-39 - 3 seconds ago
- Magnesium Gluconate and Rash for Women aged 30-39 - 3 seconds ago
- Drug interactions of Keppra and Takhzyro - 4 seconds ago